The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma

被引:14
作者
Richards, SJ [1 ]
Jack, AS [1 ]
机构
[1] Gen Infirm, Haematol Malignancy Diagnost Serv, Leeds LS1 3EX, W Yorkshire, England
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2003年 / 25卷 / 06期
关键词
leukaemia; lymphoma; diagnosis; specialist laboratory services;
D O I
10.1046/j.0141-9854.2003.00559.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis and monitoring of leukaemia and lymphoma requires the effective integration of a wide range of diagnostic techniques and expertise. The need to develop this type of service that crosses traditional boundaries of laboratory specialities is being recommended in national guidance. The Haematological Malignancy Diagnostic Service based within the Leeds Teaching Hospitals NHS Trust was established in 1993 to provide specialist laboratory services for the diagnosis of haematological malignancy for Yorkshire and Humberside in the UK. The department uses a wide range of methodologies including morphology, immunocytochemistry, flow cytometry and molecular genetics [fluorescent in situ hybridization (FISH) and polymerase chain reaction (PCR)] in a systematic and co-ordinated way. We describe how the department was established, its current working practices and highlight the advantages of an integrated laboratory for diagnosis of tumours of the haematopoietic system.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 11 条
[1]  
*DEP HLTH, 2003, COMP REG ACCR SCHEM
[2]  
*DEP HLTH, 2002, PATH ESS SERV GUID M
[3]   Antigen expression patterns reflecting genotype of acute leukemias [J].
Hrusák, O ;
Porwit-MacDonald, A .
LEUKEMIA, 2002, 16 (07) :1233-1258
[4]  
Jack AS, 1998, J PATHOL, V184, P231, DOI 10.1002/(SICI)1096-9896(199803)184:3<231::AID-PATH21>3.0.CO
[5]  
2-6
[6]  
Jaffe ES., 2001, CLASSIFICATION TUMOU
[7]  
*NAT I CLIN EXC, 2003, SERV GUID NHS ENGL W
[8]   What is the role of cytogenetic and molecular genetic analysis in the diagnosis of chronic myeloproliferative disorders? [J].
Owen, RG ;
Dickinson, H ;
Evans, PAS ;
O'Connor, SJM ;
Swirsky, DM ;
Jack, AS .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) :717-718
[9]   Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy [J].
Rawstron, AC ;
Kennedy, B ;
Evans, PAS ;
Davies, FE ;
Richards, SJ ;
Haynes, AP ;
Russell, NH ;
Hale, G ;
Morgan, GJ ;
Jack, AS ;
Hillmen, P .
BLOOD, 2001, 98 (01) :29-35
[10]   Lymphoid malignancies: The dark side of B-cell differentiation [J].
Shaffer, AL ;
Rosenwald, A ;
Staudt, LM .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (12) :920-932